United Therapeutics | UTHR - Cost Of Sales

Stock Price
498.51
Daily Change
-5.09 -1.01%
Monthly
4.56%
Yearly
54.04%
Q1 Forecast
458.74

United Therapeutics reported $474.7M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Amarin USD 16.89M 18.51M Mar/2025
Ardelyx USD 3.98M 10.84M Sep/2025
Baxter International USD 2.4B 512M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
BioCryst Pharmaceuticals USD 12.27M 9.04M Dec/2024
Biogen USD 810.1M 205.1M Sep/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Emergent BioSolutions USD 381.2M 226.1M Jun/2023
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Halozyme Therapeutics USD 102.15M 29.14M Dec/2025
Insmed USD 46.16M 15.25M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
J&J USD 7.97B 689M Dec/2025
Lexicon Pharmaceuticals USD 17.81M 3.41M Jun/2024
Moderna USD 452M 245M Dec/2025
Omeros USD 33.16M 18.52M Jun/2024
Pfizer USD 6.29B 2.12B Dec/2025
PTC Therapeutics USD 16.3M 7.02M Dec/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 399.38M 247.93M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025